NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) is a publicly traded Healthcare sector company. As of July 22, 2026, NRSN trades at $0.66 with a market cap of $24.89M and a P/E ratio of 0.00. NRSN moved +0.00% today. Year to date, NRSN is -8.97%; over the trailing twelve months it is -63.73%. Its 52-week range spans $0.63 to $2.60. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces NRSN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks NRSN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.66 |
| Market Cap | $24.89M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.60 |
| 52-Week Low | $0.63 |
| Volume | 75.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover NRSN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.